ES2084821T3 - Composicion para estabilizar el plasma sanguineo en curso de pasteurizado. - Google Patents
Composicion para estabilizar el plasma sanguineo en curso de pasteurizado.Info
- Publication number
- ES2084821T3 ES2084821T3 ES91912152T ES91912152T ES2084821T3 ES 2084821 T3 ES2084821 T3 ES 2084821T3 ES 91912152 T ES91912152 T ES 91912152T ES 91912152 T ES91912152 T ES 91912152T ES 2084821 T3 ES2084821 T3 ES 2084821T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- pasteurizing
- blood plasma
- course
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000002381 plasma Anatomy 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000009928 pasteurization Methods 0.000 abstract 2
- 230000000087 stabilizing effect Effects 0.000 abstract 2
- 108010091326 Cryoglobulins Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6443—Coagulation factor XIa (3.4.21.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21027—Coagulation factor XIa (3.4.21.27)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
LA INVENCION SE REFIERE A UNA COMPOSICION DESTINADA A ESTABILIZAR EL PLASMA SANGUINEO, TOTAL O DEPROVISTO DE CRIOPROTEINAS, DURANTE LA PASTEURIZACION. LA COMPOSICION SEGUN LA INVENCION PERMITE PASTEURIZAR VOLUMENES DE PLASMA MUY GRANDES (HASTA VARIOS CENTENARES DE LITROS). LA INVENCION TAMBIEN SE REFIERE AL PROCESO DE PASTEURIZACION DEL PLASMA QUE UTILIZA LA COMPOSICION ESTABILIZANTE. EL PLASMA PASTEURIZADO OBTENIDO SE DESTINA A UN USO TERAPEUTICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9008375A FR2664165B1 (fr) | 1990-07-03 | 1990-07-03 | Composition pour stabiliser le plasma sanguin en cours de pasteurisation. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2084821T3 true ES2084821T3 (es) | 1996-05-16 |
Family
ID=9398269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91912152T Expired - Lifetime ES2084821T3 (es) | 1990-07-03 | 1991-06-20 | Composicion para estabilizar el plasma sanguineo en curso de pasteurizado. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0497929B1 (es) |
JP (1) | JP3132828B2 (es) |
AT (1) | ATE135238T1 (es) |
AU (1) | AU8062991A (es) |
CA (1) | CA2065284A1 (es) |
CZ (1) | CZ281431B6 (es) |
DE (1) | DE69117920T2 (es) |
DK (1) | DK0497929T3 (es) |
ES (1) | ES2084821T3 (es) |
FI (1) | FI96918C (es) |
FR (1) | FR2664165B1 (es) |
GR (1) | GR3020048T3 (es) |
HU (1) | HU208404B (es) |
LT (1) | LT3419B (es) |
LV (1) | LV10384B (es) |
NO (1) | NO179127C (es) |
PL (1) | PL166579B1 (es) |
PT (1) | PT98190B (es) |
RU (1) | RU2045902C1 (es) |
SK (1) | SK279031B6 (es) |
WO (1) | WO1992000767A1 (es) |
ZA (1) | ZA914848B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687317B1 (fr) | 1992-02-13 | 1995-06-23 | Aetsrn | Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique. |
DE4240103A1 (de) * | 1992-05-26 | 1993-12-02 | Behringwerke Ag | Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen |
DE19508192A1 (de) * | 1995-03-09 | 1996-09-12 | Behringwerke Ag | Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung |
US20060019234A1 (en) * | 2004-07-22 | 2006-01-26 | Shanbrom Technologies, Llc | Modern blood banking employing improved cell preservation composition |
WO2017155678A1 (en) * | 2016-03-10 | 2017-09-14 | Kindheart, Inc | Fake blood for use in simulated surgical procedures |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2916711A1 (de) | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
EP0035204B2 (en) | 1980-03-05 | 1991-05-22 | Miles Inc. | Pasteurized therapeutically active protein compositions |
DE3045153A1 (de) * | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
DE3336631A1 (de) * | 1983-10-08 | 1985-04-18 | Behringwerke Ag, 3550 Marburg | Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x |
US4543210A (en) * | 1984-10-04 | 1985-09-24 | Miles Laboratories, Inc. | Process for producing a high purity antihemophilic factor concentrate |
DK18288D0 (da) * | 1988-01-15 | 1988-01-15 | Nordisk Gentofte | Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii |
-
1990
- 1990-07-03 FR FR9008375A patent/FR2664165B1/fr not_active Expired - Lifetime
-
1991
- 1991-06-20 AT AT91912152T patent/ATE135238T1/de not_active IP Right Cessation
- 1991-06-20 WO PCT/FR1991/000493 patent/WO1992000767A1/fr active IP Right Grant
- 1991-06-20 ES ES91912152T patent/ES2084821T3/es not_active Expired - Lifetime
- 1991-06-20 SK SK579-92A patent/SK279031B6/sk not_active IP Right Cessation
- 1991-06-20 HU HU92701A patent/HU208404B/hu unknown
- 1991-06-20 DE DE69117920T patent/DE69117920T2/de not_active Expired - Lifetime
- 1991-06-20 RU SU915011827A patent/RU2045902C1/ru active
- 1991-06-20 AU AU80629/91A patent/AU8062991A/en not_active Abandoned
- 1991-06-20 JP JP03511111A patent/JP3132828B2/ja not_active Expired - Lifetime
- 1991-06-20 DK DK91912152.5T patent/DK0497929T3/da active
- 1991-06-20 PL PL91294037A patent/PL166579B1/pl unknown
- 1991-06-20 CA CA002065284A patent/CA2065284A1/fr not_active Abandoned
- 1991-06-20 EP EP91912152A patent/EP0497929B1/fr not_active Expired - Lifetime
- 1991-06-24 ZA ZA914848A patent/ZA914848B/xx unknown
- 1991-07-02 PT PT98190A patent/PT98190B/pt not_active IP Right Cessation
-
1992
- 1992-02-27 CZ CS92579A patent/CZ281431B6/cs not_active IP Right Cessation
- 1992-02-28 NO NO920791A patent/NO179127C/no not_active IP Right Cessation
- 1992-03-02 FI FI920934A patent/FI96918C/fi not_active IP Right Cessation
- 1992-12-24 LV LVP-92-497A patent/LV10384B/xx unknown
- 1992-12-29 LT LTIP264A patent/LT3419B/lt not_active IP Right Cessation
-
1996
- 1996-05-27 GR GR960401411T patent/GR3020048T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2032316T3 (es) | Procedimiento para la esterilizacion de plasma o fracciones de plasma. | |
ES2035384T3 (es) | Procedimiento para la esterilizacion de sangre, plasma, derivados de la sangre y del plasma, suspensiones celulares o similares. | |
NO832977L (no) | Pasteurisert human-fibrinogen (hf), fremgangsmaate til dets fremstilling og dets anvendelse | |
BR9300524A (pt) | Composicao para estabilizar o plasma sanguineo durante a pasteurizacao e solucao plasmatica prasteurizada de uso terapuetico | |
RU93004727A (ru) | Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии | |
ES2084821T3 (es) | Composicion para estabilizar el plasma sanguineo en curso de pasteurizado. | |
ES2066753T3 (es) | Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas. | |
ES499363A0 (es) | Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles | |
DE3676640D1 (de) | Prazosin-pirbuterol-mischung zur bronchendilatation. | |
ATE129895T1 (de) | Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten. | |
DE68916777T2 (de) | Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. | |
ZA893310B (en) | Novel strobilurine derivatives,their preparation and their use | |
ES2078305T3 (es) | 2-alquil-3-benzoilbenzofuranos utiles para el tratamiento de la arritmia cardiaca. | |
FR2553407B1 (fr) | Derives de n-(4-acetylaminophenacyl)-amine, leur utilisation en therapeutique et leur procede de preparation | |
ITAP930004U1 (it) | Sistema di correzione del procurvato e del recurvato per allungatori di arti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 497929 Country of ref document: ES |